Literature DB >> 8794870

Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding.

F P Lindberg1, H D Gresham, M I Reinhold, E J Brown.   

Abstract

Integrin-associated protein (IAP/CD47) is physically associated with the alpha v beta 3 vitronectin (Vn) receptor and a functionally and immunologically related integrin on neutrophils (PMN) and monocytes. Anti-IAP antibodies inhibit multiple phagocyte functions, including Arg-Gly-Asp (RGD)-initiated activation of phagocytosis, chemotaxis, and respiratory burst; PMN adhesion to entactin; and PMN transendothelial and transepithelial migration at a step subsequent to tight intercellular adhesion. Anti-IAP antibodies also inhibit binding of Vn-coated particles to many cells expressing alpha v beta 3. However, prior studies with anti-IAP did not directly address IAP function because they could not distinguish between IAP blockade and antibody-induced signaling effects on cells. To better determine the function of IAP, we have characterized and used an IAP-deficient human cell line. Despite expressing alpha v integrins, these cells do not bind Vn-coated particles unless transfected with IAP expression constructs. Increasing the level of alpha v beta 3 expression or increasing Vn density on the particle does not overcome the requirement for IAP. All known splice variants of IAP restore Vn particle binding equivalently. Indeed, the membrane-anchored IAP Ig variable domain suffices to mediate Vn particle binding in this system, while the multiply membrane-spanning and cytoplasmic domains are dispensable. In all cases, adhesion to a Vn-coated surface and fibronectin particle binding through alpha 5 beta 1 fibronectin receptors are independent of IAP expression. These data demonstrate that some alpha v integrin ligand-binding functions are IAP independent, whereas others require IAP, presumably through direct physical interaction between its Ig domain and the integrin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794870      PMCID: PMC2120984          DOI: 10.1083/jcb.134.5.1313

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  40 in total

1.  A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation.

Authors:  J C Loftus; T E O'Toole; E F Plow; A Glass; A L Frelinger; M H Ginsberg
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

2.  Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers.

Authors:  A L Frelinger; I Cohen; E F Plow; M A Smith; J Roberts; S C Lam; M H Ginsberg
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

Authors:  M J Elices; L Osborn; Y Takada; C Crouse; S Luhowskyj; M E Hemler; R R Lobb
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

5.  Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins.

Authors:  E Brown; L Hooper; T Ho; H Gresham
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

6.  The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus.

Authors:  D E Staunton; M L Dustin; H P Erickson; T A Springer
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.

Authors:  M E Medof; D M Lublin; V M Holers; D J Ayers; R R Getty; J F Leykam; J P Atkinson; M L Tykocinski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface.

Authors:  E A Wayner; R A Orlando; D A Cheresh
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

9.  A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis.

Authors:  H D Gresham; J L Goodwin; P M Allen; D C Anderson; E J Brown
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

10.  Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1.

Authors:  C D Buckley; R Doyonnas; J P Newton; S D Blystone; E J Brown; S M Watt; D L Simmons
Journal:  J Cell Sci       Date:  1996-02       Impact factor: 5.285

View more
  24 in total

1.  CD47-dependent molecular mechanisms of blood outgrowth endothelial cell attachment on cholesterol-modified polyurethane.

Authors:  Masako Ueda; Ivan S Alferiev; Stacey B Simons; Robert P Hebbel; Robert J Levy; Stanley J Stachelek
Journal:  Biomaterials       Date:  2010-06-09       Impact factor: 12.479

2.  Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42.

Authors:  Motoaki Miyashita; Hiroshi Ohnishi; Hideki Okazawa; Hiroyasu Tomonaga; Akiko Hayashi; Tetsuro-Takahiro Fujimoto; Nobuhiko Furuya; Takashi Matozaki
Journal:  Mol Biol Cell       Date:  2004-06-23       Impact factor: 4.138

Review 3.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Anti-inflammatory effects of alphav integrin antagonism in acute kidney allograft rejection.

Authors:  Jens Bedke; Eva Kiss; Carl-Ludwig Behnes; Zoran V Popovic; Markus Heuser; Tomislav Stojanovic; Tjeerd Sijmonsma; Peter Huber; Sophie Domhan; Stefan Muschal; Amir Abdollahi; Norbert Gretz; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2007-08-16       Impact factor: 4.307

5.  Impaired memory retention and decreased long-term potentiation in integrin-associated protein-deficient mice.

Authors:  H P Chang; F P Lindberg; H L Wang; A M Huang; E H Lee
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

6.  Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Authors:  Swetha Mahesula; Itay Raphael; Rekha Raghunathan; Karan Kalsaria; Venkat Kotagiri; Anjali B Purkar; Manjushree Anjanappa; Darshit Shah; Vidya Pericherla; Yeshwant Lal Avinash Jadhav; Jonathan A L Gelfond; Thomas G Forsthuber; William E Haskins
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

Review 7.  CD47 signaling pathways controlling cellular differentiation and responses to stress.

Authors:  David R Soto-Pantoja; Sukhbir Kaur; David D Roberts
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-02-24       Impact factor: 8.250

Review 8.  Interactions of integrins with their partner proteins in leukocyte membranes.

Authors:  Howard R Petty; Randall G Worth; Robert F Todd
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

9.  CD98 activation increases surface expression and clusteringof beta1 integrins in MCF-7 cells through FAK/Src- and cytoskeleton-independent mechanisms.

Authors:  Sun Mi Kim; Jang Hee Hahn
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

10.  A molecule bearing an immunoglobulin-like V region of the CTX subfamily in amphioxus.

Authors:  Akie Sato; Werner E Mayer; Jan Klein
Journal:  Immunogenetics       Date:  2003-07-30       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.